JP2024532426A5 - - Google Patents
Info
- Publication number
- JP2024532426A5 JP2024532426A5 JP2024513388A JP2024513388A JP2024532426A5 JP 2024532426 A5 JP2024532426 A5 JP 2024532426A5 JP 2024513388 A JP2024513388 A JP 2024513388A JP 2024513388 A JP2024513388 A JP 2024513388A JP 2024532426 A5 JP2024532426 A5 JP 2024532426A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv infection
- gene
- sequence
- gene coding
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/115420 | 2021-08-30 | ||
| CN2021115420 | 2021-08-30 | ||
| PCT/CN2022/115822 WO2023030312A1 (zh) | 2021-08-30 | 2022-08-30 | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532426A JP2024532426A (ja) | 2024-09-05 |
| JP2024532426A5 true JP2024532426A5 (https=) | 2025-09-09 |
Family
ID=85410863
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024513388A Pending JP2024532426A (ja) | 2021-08-30 | 2022-08-30 | エイズウイルス感染の遺伝子治療用の遺伝子配列構築体 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240391981A1 (https=) |
| EP (1) | EP4397748A4 (https=) |
| JP (1) | JP2024532426A (https=) |
| CN (1) | CN117980465A (https=) |
| AU (1) | AU2022338817A1 (https=) |
| CA (1) | CA3230492A1 (https=) |
| WO (1) | WO2023030312A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114645066B (zh) * | 2020-12-21 | 2023-08-25 | 康霖生物科技（杭州）有限公司 | 一种用于艾滋病基因治疗的核酸构建体 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19957838C2 (de) * | 1999-11-25 | 2002-11-21 | Pette Heinrich Inst | Gentherapie von HIV-Infizierten durch Expression von Membran-verankerten gp41-Peptiden |
| CN101500615A (zh) * | 2006-08-17 | 2009-08-05 | 霍夫曼-拉罗奇有限公司 | 针对ccr5的抗体和抗融合肽的缀合物 |
| AU2013251184A1 (en) * | 2007-07-20 | 2013-11-14 | F.Hoffmann-La Roche Ag | A conjugate of an antibody against CD4 and antifusogenic peptides |
| US8828932B2 (en) * | 2010-05-03 | 2014-09-09 | New York Blood Center, Inc. | Bifunctional molecules for inactivating HIV and blocking HIV entry |
| JP7237449B2 (ja) * | 2015-02-27 | 2023-03-13 | アイセル・ジーン・セラピューティクス・エルエルシー | 血液系腫瘍を標的としたキメラ抗体受容体（ＣＡＲｓ）の構成およびその使用方法 |
| EA035332B1 (ru) * | 2015-04-24 | 2020-05-28 | ВАЙВ ХЕЛТКЕР ЮКей (№5) ЛИМИТЕД | Полипептиды, нацеленные на слияние вич |
| CN111944025B (zh) * | 2017-04-18 | 2022-06-07 | 中国医学科学院病原生物学研究所 | 艾滋病病毒膜融合抑制剂脂肽及药物用途 |
| JP7345861B2 (ja) * | 2017-12-21 | 2023-09-19 | ザ・トラスティーズ・オブ・コロンビア・ユニバーシティ・イン・ザ・シティ・オブ・ニューヨーク | 二重特異性ｈｉｖ－１中和抗体 |
| US12365722B2 (en) * | 2018-10-19 | 2025-07-22 | University Of Maryland, College Park | Multispecific antibodies targeting multiple epitopes on the HIV-1 envelope |
| CN114645066B (zh) * | 2020-12-21 | 2023-08-25 | 康霖生物科技（杭州）有限公司 | 一种用于艾滋病基因治疗的核酸构建体 |
-
2022
- 2022-08-30 CA CA3230492A patent/CA3230492A1/en active Pending
- 2022-08-30 CN CN202280056356.XA patent/CN117980465A/zh active Pending
- 2022-08-30 EP EP22863447.3A patent/EP4397748A4/en active Pending
- 2022-08-30 US US18/687,681 patent/US20240391981A1/en active Pending
- 2022-08-30 WO PCT/CN2022/115822 patent/WO2023030312A1/zh not_active Ceased
- 2022-08-30 AU AU2022338817A patent/AU2022338817A1/en active Pending
- 2022-08-30 JP JP2024513388A patent/JP2024532426A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7724814B2 (ja) | Ｈｉｖ感染症の予防または処置のための三重特異性および／または三価結合タンパク質 | |
| US11192941B2 (en) | Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof | |
| JP7143452B2 (ja) | ＣＤ４７とＳＩＲＰａの相互作用を遮断できる抗体及びその応用 | |
| EP2571898B1 (en) | High-affinity fully functional soluble single-domain human cd4, antibodies, and related fusion proteins | |
| KR20200019712A (ko) | HIV gp120 및 CD3을 표적화하는 다중특이적 항체 | |
| JP2025508118A (ja) | 新規免疫調節剤の開発および使用 | |
| WO2024125180A1 (zh) | 抗cd155的抗体及其应用 | |
| TW202305006A (zh) | 與ｃｄ４７及ｐｄ—ｌ１特異性結合的雙特異性抗體 | |
| JP2024532453A5 (https=) | ||
| JP2024532426A5 (https=) | ||
| CN118382699A (zh) | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 | |
| JP7809067B2 (ja) | 抗セラミド抗体 | |
| CN111944053A (zh) | 抗bcma的car及其表达载体和应用 | |
| JP2018534915A5 (https=) | ||
| EP4397748A1 (en) | Gene sequence construct for gene therapy for hiv infection | |
| US20240050567A1 (en) | Modified immune effector cell and use thereof | |
| WO2024017281A1 (zh) | 多特异性抗体及其用途 | |
| WO2022122788A1 (en) | Multispecific antibodies against severe acute respiratory syndrome coronavirus 2 | |
| CN114751988A (zh) | 中和冠状病毒的多特异性抗体 | |
| TW202434631A (zh) | 抗il-2抗體之使用方法 | |
| TW202506729A (zh) | Ｓｔｅａｐ２定向ｔ細胞接合物及其組成物 | |
| CN120137042A (zh) | 一种抗st2单克隆抗体与应用 | |
| NZ791361B2 (en) | Engineered anti-il-2 antibodies | |
| NZ791361A (en) | Engineered anti-il-2 antibodies | |
| BR112020025721A2 (pt) | Anticorpos que visam a gp120 do hiv e métodos de uso |